# CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

> **NCT02288195** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 663 (actual)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** capecitabine
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT02288195
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08-13
- **Primary completion:** 2021-03-17
- **Final completion:** 2024-03
- **Target enrollment:** 663 (ACTUAL)
- **Last updated:** 2023-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02288195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02288195, "CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02288195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*